Vima Therapeutics, Inc.
Vima Therapeutics develops small-molecule therapies targeting G protein-coupled receptors (GPCRs) to treat neurological and psychiatric disorders.
Website
www.vimatx.comPartner
Julie GrantInvestment
Series A
Vima Therapeutics develops small-molecule therapies targeting G protein-coupled receptors (GPCRs) to treat neurological and psychiatric disorders.
Series A